Assignee
OXEIA BIOPHARMACEUTICALS INC
US·0 granted patents·8 pending applications·0 citations·filing 2015–2023
Top patents by PatentIndex Score
8 records- 0160US2023330187A1Use of ghrelin or ghrelin variant for increasing dose intensity of chemotherapeutic agents in patients with cancerOXEIA BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0257US2026077018A1Treatment of mild traumatic brain injuryOXEIA BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0347US2023031262A1Treatment of mild traumatic brain injuryOXEIA BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0426US2020261541A1Methods of treating mild brain injuryOXEIA BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0524US2017281732A1Methods of treating mild brain injuryOXEIA BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0614US2018071367A1Methods of treating cognitive impairments or dysfunctionOXEIA BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0713US2017266257A1Methods of treating traumatic brain injuryOXEIA BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0811US2017121385A1Methods of treating neurodegenerative conditionsOXEIA BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OXEIA BIOPHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →